The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma

LTX-401 is a novel oncolytic compound designed for the local treatment of solid tumors. In the present study, we have examined the applicability and efficacy of LTX-401 in a rat model JM1 hepatocellular carcinoma, with particular interest in its ability to induce antitumor immunity. LTX-401 induces...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauseth, Brynjar, Camilio, Ketil André, Shi, Jihua, Hammarström, Clara Louise, Rekdal, Øystein, Sveinbjørnsson, Baldur, Line, Pål-Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562107/
https://www.ncbi.nlm.nih.gov/pubmed/31211244
http://dx.doi.org/10.1016/j.omto.2019.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562107/
https://www.ncbi.nlm.nih.gov/pubmed/31211244
http://dx.doi.org/10.1016/j.omto.2019.05.002

Ejemplares similares